Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Stud Health Technol Inform ; 298: 24-28, 2022 Aug 31.
Artigo em Inglês | MEDLINE | ID: mdl-36073450

RESUMO

The Digital Health Leadership Programme is commissioned by Health Education England and part of the wider NHS Digital Academy. The Programme is a consortium of Imperial College London's Institute of Global Health Innovation, The University of Edinburgh's Usher Institute and Harvard Medical School. In 2021, Health Data Research UK joined Imperial and Edinburgh to deliver phase 2. The aim is to develop a new generation of digital health leaders to drive transformation of the NHS through digitisation. Participants gain the skills and knowledge to create change so that patient care and organisational operations can benefit from the many improvements and innovations modern technology has to offer.


Assuntos
Liderança , Medicina Estatal , Academias e Institutos , Saúde Global , Promoção da Saúde , Humanos
2.
Health Aff (Millwood) ; 35(2): 301-8, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26858384

RESUMO

Every year around fourteen million people globally are infected with human papillomavirus (HPV), the sexually transmitted virus that is the cause of most cervical cancers. A number of vaccines have been developed to protect against HPV, but in many countries, HPV vaccination rates have been low compared with rates for other recommended vaccines. Parental concerns, cost, and lack of information and awareness among both health professionals and parents are cited as important barriers to HPV vaccination. In Argentina the HPV vaccine has been provided to all eleven-year-old girls since 2011 as part of a comprehensive national program to prevent cervical cancer. Coverage increased from negligible levels before 2011 to a national average of 87.9 percent for the first dose, 71.6 percent for the second dose, and 52.2 percent for the third dose in 2013. There was a large variance in HPV vaccine coverage across the country's provinces. This article describes key strategies to overcome barriers to implementation of HPV vaccination and provides recommendations for policy makers.


Assuntos
Atenção à Saúde/organização & administração , Promoção da Saúde , Programas de Imunização/organização & administração , Programas Nacionais de Saúde , Argentina , Criança , Difusão de Inovações , Feminino , Humanos , Estudos de Casos Organizacionais , Infecções por Papillomavirus/economia , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus/economia , Neoplasias do Colo do Útero/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA